Tuning cold plasma can either promote or inhibit bone formation
Cold plasma looks like the glow from the “Star Wars” blue light saber but this beam of energy, made of electrons that change polarity at micro-second or nanosecond speeds, could help bones heal faster, according to a study published August 11th in the Journal of Tissue Engineering and Regenerative Medicine.
Most people interact with plasma every day. It’s in our TVs, fluorescent lights, lightning, the aurora borealis, and the sun. However, these are all examples of hot or “thermal” plasmas. Since the discovery of cold plasma, about 20 years ago, it has been used in agriculture to sterilize the surface of fruit without damaging the delicate edibles. More recently, scientists have been performing experiments treating living animal cells and tissues with cold plasma to learn more about its potential applications in medicine.
“We’ve previously studied how different applications of cold plasma can either directly kill cells, such as in skin cancer, or help them grow, as in developing bones. In this study, we asked how cold plasma would affect the area surrounding cells, known as the extracellular matrix,” says lead author Theresa Freeman, Ph.D., Associate Professor in the Department of Orthopedic Surgery in the Sidney Kimmel Medical College at Thomas Jefferson University. The extracellular matrix around cells is made of collagen and other proteins that interact with the cells and can influence their growth and behavior. For example, the extracellular matrix can either promote or inhibit bone formation or cancer cell growth and metastasis.
“We showed that matrix treated with cold plasma generated using microsecond pulsing can promote differentiation of cells into cartilage and increase bone formation,” says Dr. Freeman. “Conversely, we showed matrix treated with nanosecond-pulsed cold plasma inhibited cell differentiation and bone formation.”
The study demonstrates that cold plasma may be “tuned” to either promote or inhibit cell/matrix interactions by chemically altering the matrix.
The researchers started their experiments by exposing a commercially available extracellular matrix, (Matrigel) to either nanosecond or microsecond pulsed cold plasma at different frequencies. When microsecond cold plasma-treated Matrigel was inserted into a mouse, cells entered the gel and began the process of bone formation. However, far fewer cells entered the nanosecond plasma-treated Matrigel, and bone formation was stunted. Using an in vitro assay, Dr. Freeman and colleagues showed that cells grown on microsecond plasma-treated collagen had higher levels of focal adhesion kinase activation, indicating better cell/matrix attachments which helps initiate bone formation. There were also higher levels of anti-apoptotic proteins, suggesting better cell viability than in nanosecond-cold plasma treated collagen.
“As research into medical applications of cold plasma expands, it will be important to study various plasma types and conditions in tissue models, rather than isolated cells,” says Dr. Freeman, “Because cold plasma affects each cell type and matrix protein to produce variable physiological effects,” says Dr. Freeman, “it’s important to study not just how each cell behaves when exposed, but how they react together within the tissue and organismal environment.”
The Latest on: Cold plasma
via Google News
The Latest on: Cold plasma
- Arrest made in cold case killing of gay American in Australiaon May 12, 2020 at 6:43 am
Three decades after Scott Johnson died in Sydney from what was initially ruled a suicide, a man has been charged with his death in an apparent gay hate crime.
- Impact on Global Plasma Therapy Market in Wake of COVID-19 Pandemicon May 11, 2020 at 1:45 pm
Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The global plasma therapy market is expected to reach US$384.94 million ...
- Space Weather Forecasting Takes Inspiration from Meteorologyon May 11, 2020 at 5:58 am
Solar features analogous to major atmospheric waves on Earth could offer more advanced warning of harmful solar storms.
- New plasma medicine research shows its antibacterial effects, potential useson May 10, 2020 at 5:01 pm
A research group has found that direct low-temperature plasma (LTP) treatment and plasma-activated media are effective treatments against bacteria found in liquid cultures. The team, consisting of ...
- Research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infectionson May 9, 2020 at 7:32 pm
As interest in the application of plasma medicine -- the use of low-temperature plasma created by an electrical discharge to address medical problems -- continues to grow, so does the need for ...
- Plasma medicine research highlights its antibacterial effects, potential useson May 8, 2020 at 11:55 pm
is using an atmospheric-pressure plasma jet to use room temperature -- "cold" -- plasma to treat bacteria. The results of the study were published in the journal IEEE Transactions on Radiation and ...
- Plasma medicine research highlights antibacterial effects and potential useson May 7, 2020 at 5:46 am
As interest in the application of plasma medicine—the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems—continues to grow, so does the need for ...
- Vehicle with expired plasma denied entryon May 6, 2020 at 10:39 am
Authorities manning the check-post on the border between Telangana and Maharashtra on NH-44 at Dollara village in Adilabad district, late on Tuesday, refused entry into the State of a vehicle carrying ...
- North America Cold Plasma Equipment Market to 2027 - Regional Analysis and Forecasts by Regime, Application and Country - ResearchAndMarkets.comon April 30, 2020 at 1:38 am
The "North America Cold Plasma Equipment Market to 2027 - Regional Analysis and Forecasts by Regime; Application; and Country" report has been added to ResearchAndMarkets.com's offering. The cold ...
- JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19on April 29, 2020 at 11:53 am
US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI) announced today that the Jerome Cana ...
via Bing News